Amneal Pharmaceuticals Ownership | Who Owns Amneal Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Amneal Pharmaceuticals Ownership Summary

Amneal Pharmaceuticals is owned by 38.60% institutional investors, 46.43% insiders, and 14.98% retail investors. Vanguard group is the largest institutional shareholder, holding 5.70% of AMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.79% of its assets in Amneal Pharmaceuticals shares.

AMRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Amneal Pharmaceuticals	38.60%	46.43%	14.98%
Sector	Healthcare Stocks	232.51%	10.72%	-143.22%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.82%	11.62%	67.56%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	17.91M	5.70%	$225.64M
Blackrock funding, inc. /de	14.30M	4.55%	$180.16M
Tpg gp a	12.33M	3.93%	$123.41M
Rubric capital management lp	12.33M	3.93%	$155.42M
Blackrock	11.28M	3.67%	$71.64M
Dimensional fund advisors lp	5.61M	1.79%	$70.68M
Morgan stanley	4.82M	1.53%	$60.71M
Geode capital management	3.99M	1.27%	$50.24M
State street	3.97M	1.27%	$39.78M
Assenagon asset management	3.76M	1.20%	$47.40M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tpg gp a	12.33M	6.72%	$123.41M
Tucker asset management	1.01M	3.71%	$12.74M
Phocas financial	1.28M	2.10%	$16.17M
Rubric capital management lp	12.33M	1.86%	$155.42M
Blackbarn capital partners lp	2.19M	1.57%	$21.92M
Nantahala capital management	2.45M	1.02%	$30.84M
Penn capital management company	1.00M	1.01%	$12.66M
Jackson creek investment advisors	222.13K	0.83%	$2.80M
Eam investors	425.72K	0.60%	$5.36M
Convergence investment partners	146.43K	0.37%	$1.85M

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	11.28M	0.00%	2.12M
Assenagon asset management	3.76M	0.07%	1.61M
Morgan stanley	4.82M	0.00%	1.32M
Penn capital management company	1.00M	1.01%	1.00M
Norges bank	889.50K	0.00%	889.50K

Top Sellers

Holder	Shares	% Assets	Change
Nantahala capital management	2.45M	1.02%	-1.78M
Fosun	-	-	-1.72M
Woodline partners lp	-	-	-1.50M
Hennessy advisors	-	-	-1.50M
Blackbarn capital partners lp	2.19M	1.57%	-1.26M

New Positions

Holder	Shares	% Assets	Change	Value
Penn capital management company	1.00M	1.01%	1.00M	$12.66M
Norges bank	889.50K	0.00%	889.50K	$11.21M
Eam investors	425.72K	0.60%	425.72K	$5.36M
Pfm health sciences, lp	355.82K	0.27%	355.82K	$3.56M
Oliver luxxe assets	156.49K	0.30%	156.49K	$1.97M

Sold Out

Holder	Change
Newedge advisors	-5.00
Global financial private client	-12.00
Wealthspire advisors	-24.00
Stephens consulting	-45.00
Wr wealth planners	-59.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	209	-16.40%	121,259,006	-19.77%	38	1.66%	107	-19.55%	65	-13.33%
Sep 30, 2025	243	1.25%	148,491,323	4.94%	47	2.33%	131	-5.76%	73	25.86%
Jun 30, 2025	235	-0.42%	141,337,020	5.14%	45	2.41%	138	-2.13%	56	5.66%
Mar 31, 2025	236	18.00%	134,653,260	6.93%	43	2.62%	142	14.52%	53	35.90%
Dec 31, 2024	199	7.57%	124,789,717	-12.50%	40	1.90%	121	32.97%	41	-28.07%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	5.61M	1.79%	-124.32K
Vanguard US Total Market Shares ETF	4.36M	1.39%	-
Vanguard Small Cap Index	4.20M	1.34%	-13.19K
iShares Russell 2000 ETF	3.65M	1.16%	-
Vanguard Small Cap Value Index Inv	2.70M	0.86%	10.25K
Vanguard Institutional Extnd Mkt Idx Tr	1.63M	0.52%	-712.55K
Fidelity Small Cap Index	1.50M	0.48%	-98.79K
Hennessy Cornerstone Growth Investor	1.50M	0.48%	-171.20K
Columbia Small Cap Value II	1.19M	0.38%	65.17K
Columbia Small Cap Value and Inflection	1.19M	0.38%	65.17K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 17, 2025	Nark Ted C	-	Sell	$586.00K
Nov 12, 2025	Shah Nikita	Executive Vice President	Sell	$1.57M
Aug 27, 2025	Kiely John	-	Sell	$295.36K
Aug 22, 2025	Shah Nikita	Executive Vice President	Sell	$1.11M
Aug 25, 2025	Shah Nikita	Executive Vice President	Sell	$60.23K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	2
2025 Q3	-	11
2025 Q2	-	7
2025 Q1	-	10
2024 Q4	-	5

AMRX Ownership FAQ

Who Owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals shareholders are primarily institutional investors at 38.60%, followed by 46.43% insiders and 14.97% retail investors. The average institutional ownership in Amneal Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Amneal Pharmaceuticals exceeds.

Who owns the most shares of Amneal Pharmaceuticals?

Amneal Pharmaceuticals’s largest shareholders are Vanguard group (17.91M shares, 5.70%), Blackrock funding, inc. /de (14.3M shares, 4.55%), and Tpg gp a (12.33M shares, 3.93%). Together, they hold 14.18% of Amneal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Amneal Pharmaceuticals?

Yes, BlackRock owns 3.67% of Amneal Pharmaceuticals, totaling 11.28M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 71.64M$. In the last quarter, BlackRock increased its holdings by 2.12M shares, a 23.11% change.

Who is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tpg gp a is Amneal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.72% of its assets in 12.33M Amneal Pharmaceuticals shares, valued at 123.41M$.

Who is the top mutual fund holder of Amneal Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Amneal Pharmaceuticals shares, with 1.79% of its total shares outstanding invested in 5.61M Amneal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools